Shinichiro Kimura

The dipeptidyl peptidase-4 inhibitor, linagliptin, improves cognitive impairment in streptozotocin-induced diabetic mice by inhibiting oxidative stress and microglial activation

Makoto Ide, Noriyuki Sonoda, Tomoaki Inoue et al. · PLoS ONE · 2020 · 48 citations · Full text

Medicine, Neurobiology, Pharmacology +17

Renoprotective effect of a novel selective PPARα modulator K-877 in db/db mice: A role of diacylglycerol-protein kinase C-NAD(P)H oxidase pathway

Toshinobu MAKI, Yasutaka Maeda, Noriyuki Sonoda et al. · Metabolism · 2017 · 45 citations

Life Sciences, Molecular Biology, Pharmacology +16

A novel DPP-4 inhibitor teneligliptin scavenges hydroxyl radicals: In vitro study evaluated by electron spin resonance spectroscopy and in vivo study using DPP-4 deficient rats

Shinichiro Kimura, Toyoshi Inoguchi, Toshihide Yamasaki et al. · Metabolism · 2015 · 36 citations

Life Sciences, Biochemistry, Pharmacology +14

Hollow fiber-combined glucose-responsive gel technology as an in vivo electronics-free insulin delivery system

Akira Matsumoto, Hirohito Kuwata, Shinichiro Kimura et al. · Communications Biology · 2020 · 18 citations · Full text

Medicine, Bioengineering, Biomedical Engineering +17

Performance evaluation of case definitions of type 1 diabetes for health insurance claims data in Japan

Tasuku Okui, Chinatsu Nojiri, Shinichiro Kimura et al. · BMC Medical Informatics and Decision Making · 2021 · 11 citations · Full text

Computing, Biomedical Informatics, Health Informatics +17